biotech · Recurrent Pericarditis · Acute Myocarditis · CRDL
Cardiol Therapeutics
Cardiol Therapeutics is a biotech organization headquartered in Toronto, CA. It trades on NYSE under ticker CRDL. Primary therapeutic focus areas include Recurrent Pericarditis, Acute Myocarditis, Spontaneous Coronary Ar
2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA HQ
2017 Founded
27 Employees
Public company Type
CRDL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA
- Founded
- 2017
- Employees
- 27
- Programs
- 11
- Drugs
- 31
- Patents
- 15
Impact of CardiolRxTM on Recurrent Pericarditis: An open label Pilot Study
Phase 1 · other · Recurrent Pericarditis
Impact of CardiolRxTM on Recurrent Pericarditis: An open label Pilot Study for Recurrent Pericarditis is a Phase 1 program (other) at Cardiol Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code Cardiol 100-004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cardiol Therapeutics
- Phase
- Phase 1
- Modality
- other
- Indication
- Recurrent Pericarditis
- Status
- active
- Trials
- 1